United States · Funded startup

Who invested in Perspective Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$175Mraised across 1 round since 2026, from 1 source

Latest round
Round, $175MFeb 2026
Investors
3
See who backed them

The rounds

  1. Feb 2026

Founders and team

From the SEC filings it signed: 4 on the team.

  • Johan (Thijs) SpoorExecutive Officer, Directori
  • Jonathan HuntExecutive Officeri
  • Mark AustinExecutive Officeri
  • Markus PuhlmannExecutive Officeri

On the board, as filediFrank MorichHeidi HensonLori WoodsRobert Williamson

Everyone who backed them

TCGPrivate equity1round
TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Perspective Therapeutics

Who invested in Perspective Therapeutics?

Perspective Therapeutics's investors include National Institutes of Health, TCG and TCG Crossover.

How much has Perspective Therapeutics raised?

Perspective Therapeutics has raised $175M across 1 round since 2026.

When did Perspective Therapeutics last raise?

Perspective Therapeutics's most recent round was an Undisclosed round of $175M in Feb 2026.

What was Perspective Therapeutics's biggest round?

Its most recent round, $175M in Feb 2026, is also its largest on record.

Who backed Perspective Therapeutics first?

Perspective Therapeutics's first round on record, in Feb 2026, was backed by National Institutes of Health, TCG and TCG Crossover.

What stage is Perspective Therapeutics at?

Perspective Therapeutics's latest named round is an Undisclosed round, in Feb 2026.

Where is Perspective Therapeutics based?

Perspective Therapeutics is based in the United States.

Companies like Perspective Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.